 |
 |

A Novel Mutation in the GLC1A Gene Causes Juvenile Open-angle Glaucoma in 4 Families From the Italian Region of Puglia
Andrea Angius, PhD;
Eliseo De Gioia, MD;
Angela Loi, MS;
Maurizio Fossarello, MD;
Gabriella Sole, PhD;
Nicola Orzalesi, MD;
Federico Grignolo, MD;
Antonio Cao, MD;
Mario Pirastu, MD
Arch Ophthalmol. 1998;116:793-797.
Background Primary open-angle glaucoma encompasses a complex of potentially blinding ocular diseases characterized by a normal-appearing angle of the anterior chamber, a characteristic degeneration of the optic nerve with resultant typical visual field defects, and usually, an elevated intraocular pressure. It can be subdivided into 2 groups according to the age at onset: the more prevalent chronic open-angle glaucoma diagnosed after 40 years of age, and the less common juvenile form, which occurs between 3 years of age and early adulthood. A locus for primary open-angle glaucoma (GLC1A) has been mapped to a 3-centimorgan region of the long arm of chromosome 1 (1q23-25). Recently, the myocilin (MYOC) gene, located in this chromosomal interval, has been found mutated in several patients affected by primary open-angle glaucoma.
Objective To describe the clinical and molecular genetic features of 4 pedigrees affected by autosomal dominant juvenile open-angle glaucoma, all from the Italian region of Puglia.
Methods Clinical study, gonioscopy, automated perimetry, and DNA analysis were performed on several members of the 4 families.
Results We identified a new molecular defect (1177GACA T) in the third exon of the GLC1A gene. This mutation is present in all affected persons and in 2 still phenotypically normal persons.
Conclusion Our results are important for diagnostic purposes because it is now possible to identify asymptomatic carriers, for whom clinical surveillance for the early detection and treatment of glaucoma may be suggested.
From the Istituto di Genetica Molecolare Consiglio Nazionale delle Ricerche, Alghero (Drs Angius and Pirastu); Clinica Oculistica Università degli Studi di Torino, Torino (Drs De Gioia and Grignolo); Istituto di Ricerca sulle Talassemie ed Anemie Mediterranee CNR, Cagliari (Ms Loi and Drs Sole and Cao); Clinica Oculistica Università degli Studi di Cagliari, Cagliari (Dr Fossarello); and Clinica Oculistica Università degli Studi di Milano, Ospedale, San Paolo (Dr Orzalesi), Italy.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
SNPs and Interaction Analyses of Noelin 2, Myocilin, and Optineurin Genes in Japanese Patients with Open-Angle Glaucoma
Funayama et al.
IOVS 2006;47:5368-5375.
ABSTRACT
| FULL TEXT
Genetic dissection of myocilin glaucoma
Gong et al.
Hum Mol Genet 2004;13:R91-102.
ABSTRACT
| FULL TEXT
A Multidomain TIGR/Olfactomedin Protein Family with Conserved Structural Similarity in the N-terminal Region and Conserved Motifs in the C-terminal Region
Green and Klein
Mol. Cell. Proteomics 2002;1:394-403.
ABSTRACT
| FULL TEXT
Genetic screening in a large family with juvenile onset primary open angle glaucoma
Booth et al.
Br. J. Ophthalmol. 2000;84:722-726.
ABSTRACT
| FULL TEXT
Myocilin Gln368stop Mutation and Advanced Age as Risk Factors for Late-Onset Primary Open-Angle Glaucoma
Angius et al.
Arch Ophthalmol 2000;118:674-679.
ABSTRACT
| FULL TEXT
Novel mutation in the MYOC gene in primary open angle glaucoma patients
VASCONCELLOS et al.
J. Med. Genet. 2000;37:301-303.
FULL TEXT
Localization of Myocilin/Trabecular Meshwork-Inducible Glucocorticoid Response Protein in the Human Eye
Karali et al.
IOVS 2000;41:729-740.
ABSTRACT
| FULL TEXT
Modulation of Myocilin/TIGR Expression in Human Trabecular Meshwork
Tamm et al.
IOVS 1999;40:2577-2582.
ABSTRACT
| FULL TEXT
|